Long-term toxicity of reduced graphene oxide nanosheets: Effects on female mouse reproductive ability and offspring development

Biomaterials

Volumn 54, Issue , 2015, Pages 188-200

  Xu, Shun ^a   Zhang, Zheyu ^a   Chu, Maoquan ^a  

^a TONGJI UNIVERSITY   (China)

Author keywords

Female mouse; Offspring health; Reduced graphene oxide nanosheets; Reproductive toxicity

Indexed keywords

DISEASES; GRAPHENE; MAMMALS; NANOSHEETS; OBSTETRICS; TOXICITY;

CANCER THERAPEUTICS; FEMALE MOUSE; GRAPHENE OXIDE NANOSHEETS; INTRAVENOUS INJECTIONS; POST-FERTILIZATION; REDUCED GRAPHENE OXIDES (RGO); REPRODUCTIVE ABILITY; REPRODUCTIVE TOXICITIES;

REDUCED GRAPHENE OXIDE;

4 (2 HYDROXYETHYL) 1 PIPERAZINEETHANESULFONIC ACID; ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; ESTROGEN; GRAPHENE OXIDE; GRAPHENE OXIDE NANOSHEET; HEMOGLOBIN; IODINE 125; NANOMATERIAL; SODIUM; UNCLASSIFIED DRUG; GRAPHITE; NANOPARTICLE; OXIDE;

ABORTION; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ATOMIC FORCE MICROSCOPY; BODY WEIGHT; CONTROLLED STUDY; ESTROGEN BLOOD LEVEL; FEMALE; FETUS; GROWTH CURVE; HEMATOCRIT; LEUKOCYTE COUNT; LONG TERM EXPOSURE; MALE; MATING; MOUSE; NONHUMAN; PLACENTA; PREGNANCY; PRENATAL EXPOSURE; PRIORITY JOURNAL; PROGENY; RADIOACTIVITY; REPRODUCTION; REPRODUCTIVE TOXICITY; SURVIVAL RATE; TRANSMISSION ELECTRON MICROSCOPY; UREA NITROGEN BLOOD LEVEL; ABNORMALITIES, DRUG-INDUCED; ANIMAL; BREEDING; CONGENITAL DISORDER; DRUG EFFECTS; INSTITUTE FOR CANCER RESEARCH MOUSE; LONGITUDINAL STUDY; MATERIALS TESTING; PATHOPHYSIOLOGY; PHYSIOLOGY;

MUS;

ABNORMALITIES, DRUG-INDUCED; ANIMALS; CONGENITAL ABNORMALITIES; FEMALE; GRAPHITE; LONGITUDINAL STUDIES; MALE; MATERIALS TESTING; MICE; MICE, INBRED ICR; NANOPARTICLES; OXIDES; PREGNANCY; PREGNANCY, ANIMAL; REPRODUCTION;

EID: 84928010669     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2015.03.015     Document Type: Article

References (29)

1. Chen J., Liu H., Zhao C., Qin G., Xi G., Li T., et al. One-step reduction and PEGylation of graphene oxide for photothermally controlled drug delivery. Biomaterials 2014, 35:4986-4995.
2. Miao W., Shim G., Kang C.M., Lee S., Choe Y.S., Choi H.G., et al. Cholesteryl hyaluronic acid-coated, reduced graphene oxide nanosheets for anti-cancer drug delivery. Biomaterials 2013, 34:9638-9647.
3. Liu J.Q., Cui L., Losic D. Graphene and graphene oxide as new nanocarriers for drug delivery applications. Acta Biomater 2013, 9:9243-9257.
4. Sun X., Liu Z., Welsher K., Robinson J.T., Goodwin A., Zaric S., et al. Nano-graphene oxide for cellular imaging and drug delivery. Nano Res 2008, 1:203-212.
5. Gollavelli G., Ling Y.C. Multi-functional graphene as an invitro and invivo imaging probe. Biomaterials 2012, 33:2532-2545.
6. Sheng Z.H., Song L., Zheng J.X., Hu D.H., He M., Zheng M.B., et al. Protein-assisted fabrication of nano-reduced graphene oxide for combined invivo photoacoustic imaging and photothermal therapy. Biomaterials 2013, 34:5236-5243.
7. Artiles M.S., Rout C.S., Fisher T.S. Graphene-based hybrid materials and devices for biosensing. Adv Drug Deliv Rev 2011, 63:1352-1360.
8. Yang K., Zhang S., Zhang G., Sun X., Lee S.T., Liu Z. Graphene in mice: ultrahigh invivo tumor uptake and efficient photothermal therapy. Nano Lett 2010, 10:3318-3323.
9. Yang K., Wan J.M., Zhang S., Tian B., Zhang Y.J., Liu Z. The influence of surface chemistry and size of nanoscale graphene oxide on photothermal therapy of cancer using ultra-low laser power. Biomaterials 2012, 33:2206-2214.
10. Tian B., Wang C., Zhang S., Feng L., Liu Z. Photothermally enhanced photodynamic therapy delivered by nano-graphene oxide. ACS Nano 2011, 5:7000-7009.
11. Zhang W., Guo Z.Y., Huang D.Q., Liu Z.M., Guo X., Zhong H.Q. Synergistic effect of chemo-photothermal therapy using PEGylated graphene oxide. Biomaterials 2011, 32:8555-8561.
12. Fan Z.J., Wang J.Q., Wang Z.F., Ran H.Q., Li Y., Niu L.Y., et al. One-pot synthesis of graphene/hydroxyapatite nanorod composite for tissue engineering. Carbon 2014, 66:407-416.
13. Sayyar S., Murray E., Thompson B.C., Gambhir S., Officer D.L., Wallace G.G. Covalently linked biocompatible graphene/polycaprolactone composites for tissue engineering. Carbon 2013, 52:296-304.
14. Chang Y., Yang S.T., Liu J.H., Dong E., Wang Y., Cao A., et al. Invitro toxicity evaluation of graphene oxide on A549 cells. Toxicol Lett 2011, 200:201-210.
15. Das S., Singh S., Singh V., Joung D., Dowding J.M., Reid D., et al. Oxygenated functional group density on graphene oxide: its effect on cell toxicity. Part Part Syst Char 2013, 30:148-157.
16. Zhang X.Y., Yin J.L., Peng C., Hu W.Q., Zhu Z.Y., Li W.X., et al. Distribution and biocompatibility studies of graphene oxide in mice after intravenous administration. Carbon 2011, 49:986-995.
17. Yang K., Gong H., Shi X.Z., Wan J.M., Zhang Y.J., Liu Z. Invivo biodistribution and toxicology of functionalized nano-graphene oxide in mice after oral and intraperitoneal administration. Biomaterials 2013, 34:2787-2795.
18. Yang K., Wan J., Zhang S., Zhang Y., Lee S.T., Liu Z. Invivo pharmacokinetics, long-term biodistribution, and toxicology of PEGylated graphene in mice. ACS Nano 2011, 5:516-522.
19. Liang S., Xu S., Zhang D., He J., Chu M. Reproductive toxicity of nanoscale graphene oxide in male mice. Nanotoxicology 2014, [Published Online: Mar 12 2014]. 10.3109/17435390.2014.893380.
20. Zhang H., Xia T., Meng H., Xue M., George S., Ji Z., et al. Differential expression of syndecan-1 mediates cationic nanoparticle toxicity in undifferentiated versus differentiated normal human bronchial epithelial cells. ACS Nano 2011, 5:2756-2769.
21. Liu S., Zeng T.H., Hofmann M., Burcombe E., Wei J., Jiang R., et al. Antibacterial activity of graphite, graphite oxide, graphene oxide, and reduced graphene oxide: membrane and oxidative stress. ACS Nano 2011, 5:6971-6980.
22. Schinwald A., Murphy F.A., Jones A., MacNee W., Donaldson K. Graphene-based nanoplatelets: a new risk to the respiratory system as a consequence of their unusual aerodynamic properties. ACS Nano 2012, 6:736-746.
23. Volarevic V., Paunovic V., Markovic Z., Simovic Markovic B., Misirkic-Marjanovic M., Todorovic-Markovic B., et al. Large graphene quantum dots alleviate immune-mediated liver damage. ACS Nano 2014, [Published Online: Nov 11, 2014]. 10.1021/nn502466z.
24. Hummers W.S., Ofeman R.E. Preparation of graphitic oxide. JAm Chem Soc 1958, 80:1339.
25. Hauck T.S., Anderson R.E., Fischer H.C., Newbigging S., Chan W.C.W. Invivo quantum-dot toxicity assessment. Small 2010, 6:138-144.
26. Reference ranges of hematology data of healthy female ICR mice were obtained from Charles River Laboratories: http://www.criver.com/files/pdfs/rms/cd1/rm_rm_d_cd1_mouse.aspx.
27. Lum G. Significance of low serum alkaline phosphatase activity in a predominantly adult male population. Clin Chem 1995, 41:515-518.
28. Corwin E.J., Guo Y., Pajer K., Lowe N., McCarthy D., Schmiege S., et al. Immune dysregulation and glucocorticoid resistance in minority and low income pregnant women. Psychoneuroendocrinology 2013, 38:1786-1796.
29. Clapp J.F. The effects of maternal exercise on fetal oxygenation and feto-placental growth. Eur J Obstet Gynecol Reprod Biol 2003, 110(Suppl.1):S80-S85.